PDL BioPharma, Inc. PDLI

Other  —  Other
Market cap
—
P/E
0.0×
Older periods Dec '19 Mar '20 Jun '20 Dec '20
ROE

+8 more TTM periods

(10.64%) (17.45%) (28.44%) —
ROA
(8.38%) (13.74%) (21.88%) 0.00%
ROIC
(13.82%) (17.50%) (24.38%) —
Return on Tangible Assets
(26.00%) (21.22%) (33.39%) —
Average Days of Receivables
43.72 53.11 43.36 —
Free Cash Flow per Share
0.59 (0.38) (0.06) —
Free Cash Flow
70.29 (46.21) (6.85) —
Piotroski F-Score
2.00 3.00 3.00 —
Other line items

Show all line items

Columns are period end dates